Find information on thousands of medical conditions and prescription drugs.

Trizivir

Trizivirâ„¢ is a combination of three drugs patented by GlaxoSmithKline. It is indicated in the treatment of AIDS/HIV.

Two of the three drugs are reverse transcriptase inhibitors:

  • abacavir
  • lamivudine

the third is an antiretroviral drug:

  • zidovudine
Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


One! Two pharmaceutical giants team up to find a simpler, better way to fight HIV
From Advocate, The, 6/21/05 by Bob Adams

Treating HIV disease could become a lot easier for many people who are on a medication regimen. Two of the world's pharmaceutical giants--Bristol-Myers Squibb and Gilead Sciences--have teamed up to create the so-called holy grail of treatment: a single pill containing an entire day's worth of antiretroviral medications.

If approved by the U.S. Food and Drug Administration, the proposed once-a-day pill containing Sustiva, Viread, and Emtriva would be the simplest anti-HIV regimen available.

AIDS treatment advocates have longed for easier-to-take courses of anti-HIV drugs since the early days of combination therapy--when 25 to 30 pills a day could be typical. Even today's simplest regimens require two to four pills daily, which some experts say still makes it burdensome to achieve near-perfect adherence. And recent studies have shown that these medications can lose their effectiveness if taken less than 95% of the time.

"I personally see a lot of patients with new infections and treatment-naive patients, and people want to start with the easiest possible dosing regimen," says Tony Mills, MD, an HIV specialist in Los Angeles who is gay and HIV-positive himself. "The easier the dosing regimen, the more likely you are to be adherent. The better you adhere, the more likely it is that your viral load will remain undetectable in the long term."

BMS spokesman Eric Miller calls the first-of-its-kind collaboration between pharmaceutical rivals an "important milestone" in HIV treatment. "It grew entirely from the companies responding to meet the growing need for increased treatment options," he says.

Because each of the component drugs in the new pill have already been approved individually by the FDA, the new combination treatment could zip through the government approval process, according to the manufacturers, and hit the market as soon as the second half of 2006.

MILESTONES

1984 Researchers discover HIV; it is three years since the first U.S. AIDS cases were reported

1987 AZT is the first medication approved to treatment HIV

1995 invirase is the first protease inhibitor approved for treatment; the era of combination therapy begins

1996 Viramune, the first drug in the third class of antiretrovirals, is approved

1997 Combivir, the first pill to combine two anti-HIV medications, is approved

2000 New medication Trizivir combines three nucleoside analogs into one pill

2002 The first one-pill-a-day formulation of one antiretroviral, Sustiva, is approved

2003 Fuzeon is the first approved medication in the fusion inhibitor class

COPYRIGHT 2005 Liberation Publications, Inc.
COPYRIGHT 2005 Gale Group

Return to Trizivir
Home Contact Resources Exchange Links ebay